ICIs inhibit the binding of programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) / PD-L2 expressed on T cells and activate them by blocking the transmission of immunosuppressive functions, resulting in anti-tumor effects [5]. This evidence concerns the gene PDCD1 and neoplasm.